Alumni
|
Who |
Years |
Current position or source of support |
|---|---|---|
| Chung, D. | 2017-2024 | Scientist, Xaira |
| Shiah, J. | 2022-2023 | Graduate Student, Yale |
| Connelly, E. | 2018-2023 | Senior Scientist, Regeneron |
| Wucherer, K. | 2020-2023 | Scientist, Scribe Therapeutics |
| Ongpipattanakul, I. | 2021-2023 | Scientist, Vicinitas Therapeutics |
| Hulce, K. | 2015-2021 | Postdoc, University of Washington |
| 2019-2021 | Graduate Student, UC Davis | |
| Bohn, M. | 2015-2021 | Associate Professor at DTU, Technical University of Denmark |
| Lourenço, A. | 2018-2021 | Scientist, Brazil |
| Basu, K. | 2016-2021 | Research Scientist, Frontier Medicines |
|
2015-2017 |
Research Scientist, Symphogen A/S |
|
| Salcedo, E. | 2014-2020 | Postdoc, Antibody Discovery |
|
2014-2016 |
Senior Scientist, In Vitro Immune Inflammation |
|
| Ravalin, M. | 2013-2019 | Postdoc, Stanford University |
|
2013-2018 |
Director of Innovation, AbbVie |
|
|
2013-2018 |
Antibody Engineering, FairJourney Biologics |
|
|
2013-2017 |
Research Scientist III, Eureka Therapeutics |
|
|
2013-2016 |
Associate Director Antibody Engineering at Charles River Laboratories | |
|
2012-2017 |
Sr. Scientist I, CytomX Therapeutics |
|
|
2012-2013 |
Director of Pharmacology and Preclinical Development at Amunix Pharmaceuticals |
|
|
Goupil, L. |
2011-2016 |
Assistant Professor at University of San Francisco |
|
2011-2016 |
Adjunct Assistant Professor, San Francisco State University |
|
|
2010-2014 |
Senior Scientist, Celgene |
|
|
Page, M. |
2010-2013 |
deceased |
|
2010-2010 |
Staff Pharmacist, Indiana University Health |
|
|
2009-2015 |
Scientist, Disease biology at Frontier Medicines |
|
|
2009-2015 |
Investigator III, Novartis Institutes |
|
|
2009-2015 |
Senior Scientist, Roche |
|
|
2009-2014 |
Assistant Professor, University of Minnesota |
|
|
2009-2011 |
Ministry of Science, Technology and Innovation (MOSTI), Malaysia |
|
|
Liang, C. |
2009-2009 |
Student Pharmacist Tuoro University College of Pharmac |
|
Reynolds, C. |
2009-2009 |
Physician, Mission Viejo |
|
2009-2009 |
Senior Director, Pharmaceutical Development, Genentech |
|
|
2008-2015 |
Scientist, Denali Therapeutics |
|
|
2008-2014 |
Chemical Scientist II, Trilo Therapeutics |
|
|
2008-2011 |
Teaching Assistant Professor at University of California, Santa Cruz |
|
|
Moore, J. |
2008-2008 |
Senior Director, Pharmaceutical Development, Genentech |
|
2007-2016 |
Specialist, UCSF |
|
|
2006-2015 |
Assistant Professor, University of California San Diego |
|
|
2006-2011 |
Life Science Writer |
|
|
2006-2010 |
Associate Professor, UT Southwestern |
|
|
Zhou M. |
2006-2008 |
ACME Bioscience, Inc., Palo Alto, California |
|
2006-2006 |
Project Manager at Enochian BioSciences Inc |
|
| Duriseti, S. | 2005-2012 | Radiation Oncologist, Washington University |
|
2005-2011 |
Investigator III, Novartis Institutes for BioMedical Research |
|
|
2005-2011 |
Scientific Program Manager at Seven Bridges |
|
|
2005-2010 |
Associate Scientific Director, Global Medical Affairs, Oncology AbbVie |
|
|
2005-2010 |
||
|
2005-2010 |
Scientist, ProLynx, Hayward, California |
|
|
2005-2007 |
Director, Public Public Health Program (International Affairs) at American Society for Microbiology |
|
|
2005-2005 |
Project Manager, Enochiian BioSciences |
|
|
2004-2010 |
Principal Scientist Autoimmune at CRISPR Therapeutics |
|
|
2004-2007 |
COO at NanoTemper Technologies Inc. |
|
|
Farady, C. |
2003-2008 |
Scientist, Novartis Basel, Switzerland |
|
2003-2007 |
Regulatory Affairs Specialist at Medtronic Inc. |
|
|
2003-2004 |
Vice President of Research, Adamas Pharmaceuticals |
|
|
2003-2004 |
CEO | Cofounder at Actym Therapeutics, Inc. |
|
|
2002-2008 |
Senior Patent Counsel at Squire Patton Bogg |
|
|
Tauheed, J. |
2002-2006 |
Graduate Student, Harvard School of Public Health in Environmental Health |
|
2002-2004 |
Ajinomoto Bio-Pharma Services, CEO and President, US |
|
|
Gonzales, Y. |
2002-2002 |
Chemist, Off Pharma Quality, CDER/FDA |
|
2001-2003 |
Biotech Consultant, Rositys Ltd. |
|
|
2001-2002 |
Associate Professor, University of San Diego |
|
|
Sun, H. |
2001-2002 |
Sr. Clinical Leader, Johnson & Johnson |
|
2000-2006 |
Vice President, Commercial Insights and Operations at Dermira |
|
|
2000-2005 |
Assistant Professor of Medicine and Genetics at Stanford University |
|
|
2000-2005 |
CEO at BenchFly, Engaged Collaboration in Education |
|
|
2000-2005 |
Director, Head of Antibody Discovery and Protein Engineering at Alector |
|
|
Barrios, A. |
2000-2003 |
Professor, University of Utah |
|
Keeling, J. |
2000-2000 |
Grad Student, John Jay College of Criminal Justice |
|
Choe, Y. |
1999-2005 |
Protein Sciences/Biologics group, STAR Therapeutics |
|
Demirjian, B. |
1999-2000 |
Internist, Kaiser Permanente |
|
Lanzo, C. |
1999-2000 |
Recruiter, Russell Reynolds Associates, Inc. |
|
Yan, K. |
1999-2000 |
Novartis, Emeryville, California |
|
1998-2002 |
Professor and Chair, Department of Chemistry and Biochemistry at San Francisco State University |
|
|
1998-2002 |
Director, External Innovation, Drug Discovery Platforms- Gene Therapy, Biologics, Small Molecules |
|
|
Castro (Rodriguez), H. |
1998-2000 |
Associate Professor, Univ. Federal, Rio de Janiero, Brazil |
|
Koike, M. |
1998-1999 |
President and CEO, BioWa Inc., Princeton, New Jersey |
|
1997-2004 |
Principal Data Scientist, RWD Oncology at Genentech |
|
|
1997-2004 |
Patent Agent at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo |
|
|
1997-2000 |
Collaborateur scientifique at Université de Genève |
|
|
1997-1997 |
Psychiatrist at Swedish Medical Center |
|
|
1997-1997 |
Co-Founder, CEO of yuFlu, Inc. |
|
|
1996-2003 |
Senior R&D Scientist at Promega |
|
|
1996-2002 |
Accomplished Innovator and Strategy Consultant |
|
|
1996-2000 |
Associate Partner/Senior Expert at McKinsey & Company |
|
|
1996-2000 |
Chief Strategic Partnerships Officer at Berkeley Lab |
|
|
1996-2000 |
Head of Commercial, Digital at Merck KGaA, Darmstadt, Germany |
|
|
1996-2000 |
Chief Scientific Officer at Abalone Bio | |
|
1996-2000 |
Patent Attorney at DuPont (formerly Genencor) |
|
|
Hudig, D. |
1996-1998 |
Professor, Immunology, University of Nevada, Reno School Of Medicine |
|
Rozzelle, J. |
1996-1998 |
Scientist, Sutro Biopharma, Inc., South San Francisco, California |
|
1995-2001 |
Competitive Analysis, Dauber Consulting |
|
|
1995-1998 |
Palo Alto Pathology, Inc., Palo Alto, California |
|
|
Brown, K. |
1994-1998 |
Professor, Univ of Texas Southwestern Medical Center, Dallas, Texas |
|
Becker, K. |
1994-1995 |
|
|
1993-2000 |
Executive Director in Drug Discovery Biology , Genomics Institute of the Novartis Research Foundation |
|
|
1993-1996 |
Vice President, CMC and Project Management at Mirum Pharmaceuticals |
|
|
Murray, I. |
1993-1995 |
New England Biolabs, Ipswich, MA |
|
1994-1995 |
Professor/Director, Tech + Narrative Lab at Pardee RAND Graduate School | |
|
1993-1994 |
Professor, University of California, Santa Cruz |
|
|
1993-1994 |
Head, Early Phase Translational Medicine Planning and Execution at Bristol-Myers Squibb | |
|
1992-1996 |
Principal Investigator, Biomedical Sciences Institutes |
|
|
Endres, N. |
1992-1992 |
Scientist at Genentech |
|
Kelly, S. |
1991-1997 |
EVP/CBO, Wu Xi App Tec |
|
1991-1997 |
Co-CEO at WuXi AppTec |
|
|
Ochoa, G.-C. |
1991-1994 |
Analyst, UBS-Warburg Investment Bank, New York, New York |
|
1990-1994 |
Professor of Environmental Biochemistry and Law at Portland State University | |
|
1990-1993 |
Professor, University of Texas Southwest Medical Center, Dallas, Texas |
|
|
Gudmundsdóttir, A. |
1990-1993 |
Professor of Food Chemistry, University of Iceland, Reykjavík |
|
Li, J. |
1990-1993 |
Director, and Sheng Investment Group |
|
Salto, R. |
1990-1993 |
Professor, University of Granada, Spain |
|
1989-1994 |
Senior Scientific Officer, NIH/NIAID/DMID |
|
|
Sloane, D. |
1989-1993 |
Executive Director, Protein Biochemist |
|
Vanderslice, P. |
1989-1992 |
Director of Molecular Cardiology, Texas Heart Institute |
|
Lee, C-Y. |
1989-1990 |
Director, Bioprocessing, Merck |
|
1988-1995 |
Chair, Department of Science at The King's Academy |
|
|
1988-1995 |
Principal Scientist at Exo Therapeutics |
|
|
Willett, S. |
1988-1995 |
Director, Biopharmaceutical Development, Promedior, Inc. |
|
1988-1994 |
Genencor International, Palo Alto, California |
|
|
DeCamp, D. |
1988-1993 |
Research Associate Professor, University of Montana, Missoula |
|
Pichauntes, S. |
1987-1991 |
Research Scientist, Novartis Vaccines and Diagnostics, Inc., Emeryville, California |
|
1987-1991 |
Supervisor at Partners In Health COVID-19 Community Tracing Collaborative |
|
|
1986-1993 |
Senior Director of Structural Chemistry, Gilead Sciences, Inc. |
|
|
1986-1990 |
Director, Medivation, Inc. |
|
|
Evnin, L. |
1985-1990 |
Managing Director at MPM Capital |
|
Vasquez, J. |
1985-1990 |
Staff Scientist, SF General Hospital |